Rocket Pharmaceuticals Inc at Needham Healthcare Conference Transcript
Good morning, everyone. And thank you for joining us at the first day of Needham and Company's healthcare conference. My name is Gill Bloom, and I'm the senior biotech analyst here at Needham and Company with coverage in the gene therapy space. It is my pleasure to have with me today, Dr. Gaurav Shah, the CEO of Rocket Pharma. (Conference Instructions)
And with that, I would like to begin our conversation maybe with a bit of an introduction. So, Gaurav, could you walk us through Rocket development strategy in the gene therapy space maybe a little more broadly?
Hi. It's great to see you, Gil. Always a pleasure to talk to you and have a discussion, always highly insightful and interesting for me as well. And thank you to Needham for having us present today. So Rocket Pharma, we're a gene therapy company. Our philosophy is to essentially tackle diseases with high unmet need using a potentially curative gene therapy approach.
And we try to tackle
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
